biotech · NSCLC Stage IV · Poliomyelitis
BioMarin Pharmaceutical
Biotech Pharmaceutical Co.,
BioMarin Pharmaceutical clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 770 Lindaro Street, San Rafael, CA 94901, US
- Founded
- 1997
- Employees
- 3,171
- Programs
- 40
- Drugs
- 37
- Patents
- 0
BioMarin Pharmaceutical projects
8 ClinicalTrials.gov programs sponsored by BioMarin Pharmaceutical.
BioMarin Pharmaceutical has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CD19-TriCAR-T/SILK
Biotech Pharmaceutical Co.,
Non-Hodgkin Lymphoma
1 trial -
LBT-3627
Biotech Pharmaceutical Co.,
Parkinson Disease
1 trial -
Nimotuzumab
Biotech Pharmaceutical Co.,
Solid Tumors
1 trial -
Nimotuzumab and chemotherapy
Biotech Pharmaceutical Co.,
Non-small Cell Lung Cancer
1 trial -
Pegfilgrastim
Biotech Pharmaceutical Co.,
Breast Cancer
1 trial -
Peginterferon lambda
Biotech Pharmaceutical Co.,
Hepatitis C
1 trial -
TSB-9-W1
Biotech Pharmaceutical Co.,
Metastatic Colorectal Cancer
1 trial -
Tuberculosis Vaccine
Biotech Pharmaceutical Co.,
Tuberculosis
1 trial
Frequently asked questions
How many clinical projects does BioMarin Pharmaceutical have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.